HomeACOR • NASDAQ
Follow
Acorda Therapeutics Inc
Previous close
$11.91
Day range
$11.82 - $12.39
Year range
$8.98 - $24.20
Market cap
15.03M USD
Avg Volume
4.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 27.72M | -17.30% |
Operating expense | 30.84M | 0.51% |
Net income | -8.89M | 35.85% |
Net profit margin | -32.07 | 22.42% |
Earnings per share | — | — |
EBITDA | 195.00K | 111.01% |
Effective tax rate | 10.61% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 32.47M | 56.88% |
Total assets | 366.34M | -6.86% |
Total liabilities | 307.39M | -3.21% |
Total equity | 58.96M | — |
Shares outstanding | 1.24M | — |
Price to book | 0.25 | — |
Return on assets | -5.28% | — |
Return on capital | -7.81% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -8.89M | 35.85% |
Cash from operations | 7.61M | 513.70% |
Cash from investing | -220.00K | -46.67% |
Cash from financing | — | — |
Net change in cash | 7.23M | 412.76% |
Free cash flow | 17.18M | 270.49% |
About
Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York. The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija and Ampyra in the United States. Wikipedia
Founded
1995
Website
Employees
111